Comments
Loading...

Protagonist Therapeutics

PTGXNASDAQ
Logo brought to you by Benzinga Data
$46.58
0.430.93%
At Close: -
$47.04
0.460.99%
After Hours: 7:36 PM EDT
15 minutes delayed
62.5%
Overview Rating
Good
Technicals Analysis
100
0100
Financials Analysis
40
0100

Protagonist Therapeutics (NASDAQ:PTGX) Stock Quotes, Forecast and News Summary

Protagonist Therapeutics Stock (NASDAQ: PTGX) stock price, news, charts, stock research, profile.

40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
0
0
0
0
May
0
0
0
0
Jun
1
Jul
0
0
0
0
Aug
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$47.10
Close$46.58
Volume / Avg.773.21K / 978.41K
Day Range$46.16 - $47.61
52 Wk Range13.72 - 48.00
Market Cap$2.77B
P/E Ratio16.97
Dividend Yield-
ExchangeNASDAQ
RSI
65
Short Interest
5.64%
Days to Cover6.07
About Protagonist Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary tech...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
PTGX
IDYA

FAQ

Q

How do I buy Protagonist Therapeutics (PTGX) stock?

A

You can purchase shares of Protagonist Therapeutics (NASDAQ:PTGX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Protagonist Therapeutics (PTGX) competitors?

Q

What is the forecast, or price target, for Protagonist Therapeutics (PTGX) stock?

A

Protagonist Therapeutics has a consensus price target of $50.17.

Q

What is the current price for Protagonist Therapeutics (PTGX)?

A

The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $47.04 last updated September 24, 2024 at 7:36 PM EDT.

Q

Does Protagonist Therapeutics (PTGX) pay a dividend?

A

There are no upcoming dividends for Protagonist Therapeutics.

Q

When is Protagonist Therapeutics (NASDAQ:PTGX) reporting earnings?

A

Protagonist Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.

Q

Is Protagonist Therapeutics (PTGX) going to split?

A

There is no upcoming split for Protagonist Therapeutics.

Q

What sector and industry does Protagonist Therapeutics (PTGX) operate in?

A

Protagonist Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch